NDC 83021-0553-60: Anubis Barcelona DMAE, ZIRHAFIRM 5.988 g/60mL; .0006 g/60mL; .0006 g/60mL; 2.496 g/60mL; .456 g/60mL; 1.2 g/60mL; 1.5 g/60mL; .024 g/60mL; .18 g/60mL Cream, 60 mL Jar
This is a package of 60 mL of Anubis Barcelona DMAE, ZIRHAFIRM 5.988 g/60mL; .0006 g/60mL; .0006 g/60mL; 2.496 g/60mL; .456 g/60mL; 1.2 g/60mL; 1.5 g/60mL; .024 g/60mL; .18 g/60mL Cream from ANUBIS COSMETICS SL, first listed with the FDA Jan 2023 and currently FDA-listed, this package's marketing is listed to end Mar 2028. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 83021-553-60 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 83021 labeler · 553 product · 60 package
- Package marketed since
- Jan 13, 2023
- Package marketing ended
- Mar 6, 2028
- Sample package
- No — commercial package
- Barcode (UPC)
- 8436019954553
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Anubis Barcelona DMAE is a topical cream marketed as an over-the-counter monograph product. It contains a blend of botanical extracts (aloe vera leaf, jujube seed, and leuzea carthamoides root), humectants and emollients (glycerin, lecithin, and various alcohols and oils), and fragrance components. Products of this type are typically used for skin conditioning and moisturizing purposes. The formula also includes compounds such as baicalin and eugenol, which are commonly used in skincare products for their potential anti-inflammatory or soothing properties.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 83021-0553-60 You're viewing this Main listing | 60 mL in 1 JAR | 2023-01-13 | Mar 6, 2028 | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Anubis Barcelona 5.988 g/60mL; .0006 g/60mL; .0006 g/60mL; 2.496 g/60mL; .456 g/60mL; 1.2 g/60mL; 1.5 g/60mL; .024 g/60mL; .18 g/60mLthis 83021-0553-60 | ANUBIS | 60 ml | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
0.0018 g / 60 mL
UNII 2968PHW8QP
A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
-
0.012 g / 60 mL
UNII D240J05W14
A compound containing deanol, an organic chemical that acts as a stabilizer and pH buffer in medications. It helps maintain the product's chemical balance and shelf stability.
-
3 g / 60 mL
UNII WH8T92A065
A fatty acid derivative made by combining stearic acid with glycerin and citric acid. It acts as an emulsifier to help mix oil and water-based ingredients, and also serves as a thickener in the medicine formulation.
-
0.006 g / 60 mL
UNII YSE9PPT4TH
Hyaluronate sodium is a natural carbohydrate that holds moisture. It's used in medicines as a lubricant, thickener, and moisture-retaining agent to improve texture and delivery of the active ingredient.
-
0.0006 g / 60 mL
UNII 23AS6RA25L
A mixture of plant-derived fats and citric acid that acts as an emulsifier and solubilizer in medicines. It helps blend oil and water-based ingredients together and improves how the body absorbs certain drugs.
-
0.054 g / 60 mL
UNII 88496G1ERL
Sodium phytate is a plant-derived salt used in medications as a chelating agent and preservative. It helps stabilize formulations and may improve how the body absorbs certain minerals in the medicine.
-
0.012 g / 60 mL
UNII 1VPU26JZZ4
Potassium sorbate is a salt derived from sorbic acid, a naturally occurring preservative. It prevents growth of mold, yeast, and some bacteria, extending the medicine's shelf life.
-
0.006 g / 60 mL
UNII OJ245FE5EU
Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
-
0.042 g / 60 mL
UNII 55X04QC32I
A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
9 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from ANUBIS COSMETICS SL labeler code 83021
- AnubisMed Glycolic Acid, Citric Acid, Lactic Acid, Kojic Acid 17 g/50mL; 2.5 g/50mL; 1 g/50mL; .25 g/50mL; 5 g/50mL; .225 g/50mL; .5 g/50mL; .34875 g/50mL; 6.3 mL/50mL Liquid NDC 83021-401-50
- AnubisMed Azelaic Acid, Salicylic Acid 7 g/50mL; 400 4.9965 g/50mL; 10 g/50mL; 2.7 g/50mL; 1.62 mL/50mL; 1 g/50mL; 22.68 mL/50mL Liquid NDC 83021-402-50
- Anubis Barcelona Proteoglycan, Glycerin, Butylene Glycol .162 g/20mL; .08 g/20mL; .024 g/20mL; 16.4578 mL/20mL; .46 g/20mL; .4 g/20mL; 20 .2 g/20mL; .0002 g/20mL; 4 .002 g/20mL; 13576 .03 g/2 Concentrate NDC 83021-495-20
- Anubis Barcelona Ferulic Acid, Vitamin C, DMAE .96 mL/20mL; .02 g/20mL; .12 g/20mL; 14.26 mL/20mL; 2 g/20mL; 35 CASTOR OIL .18 g/20mL; 13576 .02 g/20mL; 2 g/20mL; .1 g/20mL Concentrate NDC 83021-501-20
- Anubis Barcelona DMAE .555 g/30mL; .243 g/30mL; .09 g/30mL; 13576 .027 g/30mL; .024 g/30mL; .0012 g/30mL; 1000 MW) .0009 g/30mL; .0003 g/30mL; .0006 g/3 Concentrate NDC 83021-546-30
- AnubisMed SPF 50 Broad Spectrum Protection Fluid Emulsion .025 g/50mL; .005 g/50mL; .00275 g/50mL; .22 g/50mL; 1.8 g/50mL; .0018 g/50mL; 2.5 g/50mL; 27.55 mL/50mL; 135 Cream NDC 83021-551-50
- Anubis Barcelona Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Allantoin .0000001 g/5mL; .0125 g/5mL; .0025 g/5mL; 5 .00001 g/5mL; .0069 g/5mL; .000035 g/5mL; .00500065 g/5mL; .01 g/5mL; 3.12515585 mL/5mL Concentrate NDC 83021-617-05
- Anubis Barcelona Regul OIl Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Arctium Majus Root Extract 3.512 mL/10mL; 40 HYDROGENATED CASTOR OIL .04 g/10mL; .0345 g/10mL; .0138 g/10mL; .00007 g/10mL; .025 g/10mL; .0006 g/10mL; .0000002 g/10mL Concentrate NDC 83021-624-10
- Anubis Barcelona Protective Line Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene 3.5982 g/50mL; .425 g/50mL; .1 g/50mL; 1.8 g/50mL; 2.5 g/50mL; 2.5 g/50mL; 2.1 g/50mL; 450000 MW) 27.55 mL/50mL; .575 g/50mL Cream NDC 83021-686-50
- Anubis Barcelona Total Hydrating Betaine, Glycerin, Polysorbate 20 5 g/250mL; 13576 .125 g/250mL; 1 .00025 g/250mL; 1.75 g/250mL; 5 g/250mL; 2.25 g/250mL; .125 g/250mL; 20 2.75 g/250mL; 232.139 mL/250mL; .75 Lotion NDC 83021-692-01
- Anubis Barcelona Regul Oil Propylene Glycol, Panthenol, Thiamine HCL 52.5 mL/250mL; .025 g/250mL; .25 g/250mL; .0225 g/250mL; .0025 g/250mL; 40 HYDROGENATED CASTOR OIL 2 g/250mL; .5 g/250mL; .14375 g/250mL Lotion NDC 83021-740-01
- Anubis Barcelona Regul Oil Cetearyl Ethylhexanoate, Propylene Glycol, Glyceryl Stearate Se .08784 g/200mL; .003398 g/200mL; .002132 g/200mL; 3.5436 mL/200mL; 1.6 g/200mL; 1.3 g/200mL; .1 g/200mL; .4 g/200mL; 155.839258 mL/200mL Cream NDC 83021-742-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
D-lift cream indications
⏱️ Dosage and Administration ▾
D-lift cream dosage
⚠️ Warnings ▾
D-lift cream warnings
🧪 Active Ingredient ▾
D-lift cream act ingredient
🧪 Inactive Ingredients ▾
D-lift cream inac ingredients
🎯 Purpose ▾
D-lift cream purpose
📄 Do Not Use ▾
D-lift cream dnu
📄 Keep Out of Reach of Children ▾
D-lift cream keep
📄 Package Label / Principal Display Panel ▾
D-lift cream label
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |